Mondelez International, Inc.
Mondelez International, Inc. (MDLZ) Financial Performance & Income Statement Overview
Analyze Mondelez International, Inc. (MDLZ) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Mondelez International, Inc. (MDLZ) Income Statement & Financial Overview
Review Mondelez International, Inc. MDLZ income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $9.31B | $9.60B | $9.20B | $8.34B |
Cost of Revenue | $6.88B | $5.89B | $6.21B | $5.55B |
Gross Profit | $2.43B | $3.71B | $3.00B | $2.80B |
Gross Profit Ratio | $0.26 | $0.39 | $0.33 | $0.34 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.71B | $1.98B | $1.63B | $1.89B |
Operating Expenses | $1.71B | $2.10B | $1.85B | $1.94B |
Total Costs & Expenses | $8.59B | $7.99B | $8.05B | $7.49B |
Interest Income | $0.00 | $93.00M | $83.00M | $98.00M |
Interest Expense | $0.00 | $127.00M | $129.00M | $130.00M |
Depreciation & Amortization | $324.00M | $331.00M | $335.00M | $317.00M |
EBITDA | $1.006B | $2.06B | $1.60B | $1.30B |
EBITDA Ratio | $0.11 | $0.21 | $0.17 | $0.16 |
Operating Income | $680.00M | $1.61B | $1.15B | $854.00M |
Operating Income Ratio | $0.07 | $0.17 | $0.13 | $0.10 |
Other Income/Expenses (Net) | -$135.00M | -$14.00M | -$21.00M | -$4.00M |
Income Before Tax | $545.00M | $1.60B | $1.13B | $850.00M |
Income Before Tax Ratio | $0.06 | $0.17 | $0.12 | $0.10 |
Income Tax Expense | $154.00M | $216.00M | $326.00M | $295.00M |
Net Income | $402.00M | $1.75B | $853.00M | $601.00M |
Net Income Ratio | $0.04 | $0.18 | $0.09 | $0.07 |
EPS | $0.31 | $1.30 | $0.64 | $0.45 |
Diluted EPS | $0.31 | $1.30 | $0.63 | $0.45 |
Weighted Avg Shares Outstanding | $1.34B | $1.34B | $1.34B | $1.34B |
Weighted Avg Shares Outstanding (Diluted) | $1.34B | $1.34B | $1.34B | $1.35B |
The company's financials show resilient growth, with revenue advancing from $8.34B in Q2 2024 to $9.31B in Q1 2025. Gross profit remained healthy with margins at 26% in Q1 2025 compared to 34% in Q2 2024. Operating income hit $680.00M last quarter, sustaining a consistent 7% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.006B. Net income dropped to $402.00M, while earnings per share reached $0.31. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan